GILEAD SCIENCES, INC. Undistributed Earnings of Foreign Subsidiaries
GILEAD SCIENCES, INC. (GILD) had Undistributed Earnings of Foreign Subsidiaries of $37.60 billion as of 2016-12-31, per its 10-K filed 2017-02-27.
Discontinued › Notes › Income Taxes
us-gaap:UndistributedEarningsOfForeignSubsidiaries · last filed 2017-02-27
- 2016-12-31: Undistributed Earnings of Foreign Subsidiaries $37.60B.
- 2015-12-31: Undistributed Earnings of Foreign Subsidiaries $28.50B.
- 2014-12-31: Undistributed Earnings of Foreign Subsidiaries $15.60B.
- 2013-12-31: Undistributed Earnings of Foreign Subsidiaries $8.60B; Undistributed Earnings of Foreign Subsidiaries as first filed $8.55B.
| Period end | Undistributed Earnings of Foreign Subsidiaries | Undistributed Earnings of Foreign Subsidiaries as first filed |
|---|---|---|
| 2016-12-31 | $37.60B 10-K · filed 2017-02-27 | |
| 2015-12-31 | $28.50B 10-K · filed 2017-02-27 | |
| 2014-12-31 | $15.60B 10-K · filed 2016-02-24 | |
| 2013-12-31 | $8.60B 10-K · filed 2015-02-25 | $8.55B 10-K · filed 2014-02-25 |
| 2012-12-31 | $7.25B 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |